Skip to content

The Effects of Using the Web-Based Double Eye Control Program on Medication Error

The Effects of Using the Web-Based Double Eye Control Program on Medication of High Risk Drugs in Pediatric Patients: The Effect of Web-Based Double Eye Control Program

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06371690
Enrollment
1070
Registered
2024-04-17
Start date
2017-11-01
Completion date
2018-09-30
Last updated
2024-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Main Heading (Descriptor) Terms

Keywords

Child, Child Nursing, High-Risk Drugs, Medication Error, Error Prevention Strategies

Brief summary

Methods: The study was carried out as a quasi-experimental study in the Pediatric Surgery Clinics of a university hospital using the Pre-Test-Post-Test Model in a Single Group. The sample of the study consisted of all high-risk drugs administered by 24 nurses working in these clinics, taking part in medication and agreeing to take part in the study. Data were collected by the researcher using the Medication Observation Form. The Form was created based on the literature, and by making use of the 10 Correct Rules in Medication and the Medication Skills Steps in the Double Eye Control Program. In the first step, medication error rates were determined through observation method. In the second step; the Web-Based Double-Eye Control Program, which is a standard drug dose calculation and medication program created by the researchers, was started to be implemented. Medication error rates were determined again through post-intervention observation method. Informed voluntary consent, ethics committee and hospital permissions were obtained for the implementation of the study.

Detailed description

Background: In this study, it was aimed to examine the effect of using Web Based Double-Eye Control Program as a new decision support system in preventing errors and standardization in high-risk medications of pediatric nurses. Methods: The study was carried out as a quasi-experimental study in the Pediatric Surgery Clinics of a university hospital using the Pre-Test-Post-Test Model in a Single Group. The sample of the study consisted of all high-risk drugs (532 before the intervention, 538 after the intervention, a total of 1070 drug doses) administered by 24 nurses working in these clinics, taking part in medication and agreeing to take part in the study. Data were collected by the researcher using the Medication Observation Form. The Form was created based on the literature, and by making use of the 10 Correct Rules in Medication and the Medication Skills Steps in the Double Eye Control Program. In the first step, medication error rates were determined through observation method. In the second step; the Web-Based Double-Eye Control Program, which is a standard drug dose calculation and medication program created by the researchers, was started to be implemented. Medication error rates were determined again through post-intervention observation method. Informed voluntary consent, ethics committee and hospital permissions were obtained for the implementation of the study.

Interventions

OTHERWeb-Based Double-Eye Control Program

Web-Based Double-Eye Control Program, a web-based drug dose calculation program, is compatible with smartphones, tablets and computers. On the interface of the website, the nurse is required to enter data such as the age, weight, medications and doses ordered by the physician of the patient. When all these data are entered, the amount of medication that the nurse should give and whether the ordered dose is within the safe dose range for the patient are calculated by the program, so that the nurse can control her own calculations. On the other interface of the website, there are medication instructions uploaded by the researchers. With this interface, nurses access all pharmacological information about especially high-risk drugs (indications, contraindications, interacting drugs and fluids, fluids to be used for diluting, medication route, medication pace, etc.) and information that will enable the medication to be carried out in a standard way.

Sponsors

Ege University
CollaboratorOTHER
Izmir Katip Celebi University
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* The medications observed were to be in the high-risk drug group for children, * Volunteering of nurses working in the clinic to participate in the research, * Nurses working in the clinic should have had proper level of internet usage knowledge to use a web-based program.

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Error ratesBetween January 2017 and September 2018Medication errors during administration of high-risk drugs in pediatric patients

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026